Holen Sie sich die Stockscreener-App
24.56
0.86%
0.22
Schlusskurs vom Vortag:
$24.34
Offen:
$24.37
24-Stunden-Volumen:
270.52K
Relative Volume:
0.52
Marktkapitalisierung:
$1.37B
Einnahmen:
$3.18B
Nettoeinkommen (Verlust:
$24.08M
KGV:
53.85
EPS:
0.4561
Netto-Cashflow:
$104.49M
1W Leistung:
+2.21%
1M Leistung:
+20.76%
6M Leistung:
-13.40%
1J Leistung:
-20.83%
1-Tages-Spanne:
$23.96
$24.89
1-Wochen-Bereich:
$23.58
$24.89
52-Wochen-Spanne:
$18.08
$34.80
Astrana Health Inc Stock (ASTH) Company Profile
Firmenname
Astrana Health Inc
Sektor
Branche
Telefon
(626) 282-0288
Adresse
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
24.55 | 1.35B | 3.18B | 24.08M | 104.49M | 0.4561 |
HCA
Hca Healthcare Inc
|
472.60 | 104.59B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
188.66 | 16.35B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.54 | 12.41B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
201.82 | 11.65B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
178.79 | 11.12B | 17.36B | 1.51B | 849.25M | 23.15 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Eingeleitet | Needham | Buy |
| 2025-04-01 | Eingeleitet | Barclays | Equal Weight |
| 2024-10-14 | Eingeleitet | TD Cowen | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | Hochstufung | Truist | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-26 | Eingeleitet | Jefferies | Buy |
| 2024-02-22 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-24 | Eingeleitet | Stifel | Buy |
| 2023-12-22 | Eingeleitet | Truist | Hold |
| 2023-10-17 | Eingeleitet | BTIG Research | Buy |
| 2023-04-12 | Eingeleitet | BofA Securities | Neutral |
| 2022-12-19 | Eingeleitet | Lake Street | Buy |
| 2022-09-21 | Eingeleitet | William Blair | Outperform |
| 2022-01-11 | Fortgesetzt | Colliers Securities | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Astrana Health Inc Aktie (ASTH) Neueste Nachrichten
Will Astrana Health's (ASTH) Expanded Shelf and ESOP Plans Quietly Redefine Its Capital Strategy? - simplywall.st
Astrana Health details financial impact of PHP acquisition - TipRanks
Astrana Health (NASDAQ: ASTH) shows PHP unit revenue, losses and debt - Stock Titan
Astrana Health (ASTH) CAO surrenders 662 shares for tax withholding - Stock Titan
2 Reasons to Like ASTH (and 1 Not So Much) - Yahoo Finance
Astrana Health outlines $3.8B–$4.1B 2026 revenue target amid continued full-risk expansion and operating leverage - MSN
Vanguard amends Schedule 13G: 0 shares reported for Astrana Health (ASTH) - Stock Titan
Healthcare Technology for Providers Stocks Q4 Recap: Benchmarking Astrana Health (NASDAQ:ASTH) - Yahoo Finance
If You Invested $1,000 in Astrana Health (ASTH) - Stock Titan
Is It Time To Reassess Astrana Health (ASTH) After Its Recent 22% Share Price Jump - Yahoo Finance
Astrana Health, Inc. (NASDAQ:ASTH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Block Trades: Is Astrana Health Inc impacted by rising ratesGDP Growth & Verified Short-Term Plans - baoquankhu1.vn
Targets Report: How does Astrana Health Inc. perform in inflationary periodsWeekly Investment Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Insight Wealth Strategies LLC Purchases New Position in Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
Astrana Health (ASTH) Q4 2025 Earnings Transcript - AOL.com
Astrana Health, Inc. $ASTH is 325 Capital LLC's 4th Largest Position - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Astrana Health (NASDAQ:ASTH) Price Target Raised to $38.00 at Truist Financial - MarketBeat
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $38Astrana Health (NASDAQ:ASTH) - Benzinga
Truist raises Astrana Health stock price target on earnings update By Investing.com - Investing.com South Africa
Truist raises Astrana Health stock price target on earnings update - Investing.com Nigeria
Astrana Health (NASDAQ:ASTH) Raised to "Hold" at Zacks Research - MarketBeat
OBBBA Threatens Astrana Health’s Revenue as Tighter Eligibility Rules Shrink Federally Funded Patient Base - TipRanks
Decoding Astrana Health Inc (ASTH): A Strategic SWOT Insight - GuruFocus
A Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns - simplywall.st
Astrana Health reports $3.18B revenue, $0.46 EPS in 10-K - TradingView
Astrana Health CEO Sees 20%-30% Growth in 2026 Despite Regulatory Volatility at Barclays Conference - MarketBeat
Can Astrana Health Inc sustain earnings growthMarket Growth Report & Momentum Based Trading Signals - baoquankhu1.vn
Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award™ from Healthgrades - Fidelity
Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award from Healthgrades - Finviz
Astrana Health (NASDAQ:ASTH) Shares Down 4.9%Here's Why - MarketBeat
Astrana Health, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
[Form 4] Astrana Health, Inc. Insider Trading Activity - Stock Titan
Astrana Health (ASTH) CMO surrenders shares for equity tax withholding - Stock Titan
Astrana Health (ASTH) Is Up 22.5% After Earnings Beat, Buyback Boost and 10-K DelayHas The Bull Case Changed? - simplywall.st
Astrana Health Buyback Expansion And Control Weakness Create Key Turning Point - sahmcapital.com
Astrana Health initiated as buy at Needham on valuation - MSN
Investment Report: Is Astrana Health Inc a cyclical or defensive stockJuly 2025 Earnings & Technical Confirmation Trade Alerts - baoquankhu1.vn
Astrana Health Updates Investor Presentation on Value-Based Strategy - The Globe and Mail
Astrana Health, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations - Markets Mojo
Royce & Associates LP Reduces Stock Holdings in Astrana Health, Inc. $ASTH - MarketBeat
ASTH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Astrana Health (ASTH) Still Attractive After The Recent 28% Weekly Price Jump - simplywall.st
Vanguard Group Inc. Sells 112,308 Shares of Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health : Investor Presentation – March 2026 - marketscreener.com
Astrana Health updates corporate presentation, reiterates FY2026 revenue $3.8–4.1B and Adj. EBITDA $250–280M guidance - TradingView
Astrana Health (NASDAQ: ASTH) issues 2026 growth guidance and flags control weakness - Stock Titan
Cigna CEO Cordani To Retire, Successor Named At Bloomfield-Based Health Care Giant - AOL.com
Astrana Health (ASTH +29%): Massive EPS Beat & Strong 2026 Guidance Ignites Rally - Trefis
Astrana Health to Attend Investor Conferences in March 2026 - geneonline.com
Finanzdaten der Astrana Health Inc-Aktie (ASTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Astrana Health Inc-Aktie (ASTH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
0.17%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):